Alumni Ventures Group

Alumni Ventures Group is a venture capital firm based in Manchester, New Hampshire, with offices across North America. It provides access to venture investing for individual accredited investors, particularly alumni networks, by offering diversified portfolios of venture opportunities and allowing members to invest alongside fellow alumni in ventures led by peers. The firm backs early-stage and later-stage opportunities across technology, consumer, healthcare, financial services, and other sectors, with a sector- and geography-agnostic approach. It typically invests between $10,000 and $3 million per deal and emphasizes the involvement of alumni connections and an institutional lead investor in opportunities. Alumni Ventures also offers focused funds to broaden participation, enabling accredited investors to access venture portfolios diversified by type, sector, stage, and geography. The model aims to democratize access to venture capital while maintaining rigorous selection standards through alumni networks.

Andrew Baum

Vice President, Treasury and Capital Management

David Beazley

Managing Partner

Matthew Caspari

Managing Partner

Matt Castellini

Co-Founder, CEO and Board Member

Helen Chen

CEO Services Analyst

Past deals in Hospital

Clarium Health

Venture Round in 2024
Clarium Health is a developer of an artificial intelligence-based platform aimed at enhancing healthcare operations. The company's innovative platform automates various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to accurately predict demand, allowing hospitals and healthcare centers to optimize staffing and inventory management. This capability helps prevent shortages and stockouts, reduces supplier lead times, and identifies alternative products when necessary. By empowering healthcare providers with intelligent workflow automation and actionable insights, Clarium Health is transforming the efficiency and effectiveness of healthcare delivery.

Clarium Health

Seed Round in 2023
Clarium Health is a developer of an artificial intelligence-based platform aimed at enhancing healthcare operations. The company's innovative platform automates various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to accurately predict demand, allowing hospitals and healthcare centers to optimize staffing and inventory management. This capability helps prevent shortages and stockouts, reduces supplier lead times, and identifies alternative products when necessary. By empowering healthcare providers with intelligent workflow automation and actionable insights, Clarium Health is transforming the efficiency and effectiveness of healthcare delivery.

DropStat

Venture Round in 2023
DropStat is a technology company that offers an app-based platform designed to optimize staffing for hospitals. Founded in 2017 and headquartered in Beverly Hills, California, DropStat utilizes artificial intelligence and machine learning to predict and autonomously fill staffing gaps, allowing healthcare facilities to manage labor costs more effectively. By streamlining the process of calling staff for open shifts, the platform eliminates the need for traditional communication methods such as calls and texts, thereby enhancing efficiency and reducing financial waste. In addition to improving operational processes, DropStat prioritizes data security, ensuring that sensitive information is protected both in the system and during transmission. The company's mission is to modernize shift communication, ultimately aiming to enhance both patient and staff satisfaction.

AdaptX

Series A in 2021
AdaptX is a Seattle-based healthcare technology company established in 2016, spun out from Seattle Children's Hospital. It specializes in data analytics, visualization, and AI for hospitals and surgery centers. The company's core product is a clinical healthcare analytics platform that integrates with institutions' existing electronic data systems. This platform enables medical professionals to monitor, analyze, and improve clinical outcomes and workflows, ultimately enhancing care quality and reducing costs. AdaptX empowers both medical leaders and frontline clinicians to make data-driven decisions, transforming clinical operations within healthcare providers' facilities.

STIMIT

Venture Round in 2020
STIMIT AG is a medtech company based in Nidau, Switzerland, established in 2018. The company specializes in developing innovative therapies and medical devices aimed at patients who have lost their natural breathing function, particularly those on mechanical ventilation. STIMIT's proprietary technology non-invasively activates the body's own diaphragm, which is often weakened in such patients. By strengthening diaphragm function, the company seeks to facilitate the liberation of patients from ventilators, thereby reducing the time spent on ventilation and improving overall patient outcomes. Additionally, STIMIT is working on second-generation therapies that aim to further enhance the inhalation process for patients. Through these advancements, STIMIT is positioned to significantly impact intensive care practices and improve the quality of life for patients with respiratory challenges.

Small Door

Seed Round in 2020
Small Door, Inc., established in 2017 and headquartered in New York, New York, specializes in providing elevated, customer-centric veterinary services with a focus on hospitality. The company aims to enhance the lives of pets and their owners by offering superior care, unmatched transparency, and tech-enabled convenience. Small Door operates 13 veterinary practices across New York City, Boston, and Washington DC, having conducted tens of thousands of member consultations.

Meditrina

Venture Round in 2019
Meditrina, Inc. is a medical device company based in San Jose, California, established in 2016. The company specializes in developing innovative tissue removal solutions specifically designed for intrauterine pathology. Its flagship product, the Aveta System, serves healthcare professionals by providing an all-in-one solution for hysteroscopic diagnostic and therapeutic procedures, such as the removal of polyps and fibroids. The Aveta System is notable for its compact design, which allows for seamless integration into various clinical settings, including offices and operating rooms. It features advanced capabilities such as wide-angle HD hysteroscopy, improved fluid management for better pressure control, and a small insertion diameter coupled with a large working channel, all of which contribute to optimized tissue resection and enhanced procedural efficiency.

AdaptX

Venture Round in 2019
AdaptX is a Seattle-based healthcare technology company established in 2016, spun out from Seattle Children's Hospital. It specializes in data analytics, visualization, and AI for hospitals and surgery centers. The company's core product is a clinical healthcare analytics platform that integrates with institutions' existing electronic data systems. This platform enables medical professionals to monitor, analyze, and improve clinical outcomes and workflows, ultimately enhancing care quality and reducing costs. AdaptX empowers both medical leaders and frontline clinicians to make data-driven decisions, transforming clinical operations within healthcare providers' facilities.

Bainbridge Health

Seed Round in 2018
Bainbridge Health, Inc. is a Philadelphia-based company founded in 2016 that specializes in developing a clinical intelligence and data analytics platform aimed at enhancing medication safety in hospital settings. The company's offerings include a vendor-agnostic medication safety platform that streamlines data management, reducing the reliance on manual data clerking and ad-hoc reporting. Their solutions, designed for medication safety leaders and hospital safety professionals, include an infusion pump management software known as InfusionWare, which centralizes infusion data to improve patient safety and effectively manage pump information. By mitigating medication errors, Bainbridge Health's platform helps healthcare providers reduce avoidable costs and improve overall patient care.

Heal

Series C in 2018
Heal is a healthcare provider focused on delivering value-based, in-home primary care primarily to seniors on Medicare and select Medicare Advantage plans. The company emphasizes the importance of patient comfort by offering services in the familiar environment of patients' homes. Board-certified doctors and nurse practitioners at Heal dedicate ample time to each patient, fostering strong relationships and ensuring thorough, unrushed care. Heal addresses a wide range of healthcare needs, from preventive services like flu shots and annual physicals to the management of chronic conditions and treatment of common illnesses. Additionally, the company provides telemedicine options and remote health monitoring, facilitating easy access to care when needed. Patients can schedule appointments conveniently through phone support, with availability seven days a week, including weekends and holidays.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.